Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Renal cell carcinoma.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 1 | Renal cell carcinoma |
TFE3 function has not been fully characterized.
Renal cell carcinoma, Xp11-associated is associated with mutations in the TFE3 gene on chromosome X.
Genetic testing for TFE3 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for renal cell carcinoma, Xp11-associated has been reported in the published literature.
No clinical trials have been registered for renal cell carcinoma, Xp11-associated.
157 publications have been identified in PubMed for renal cell carcinoma, Xp11-associated. Research spans Basic Science / Preclinical (26%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (18%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 41 | 26% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 5:33 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Research summaries
39 |
25% |
Testing and diagnosis research | 28 | 18% |
Disease patterns and progression | 17 | 11% |
Clinical study results | 15 | 10% |
Patient case studies | 8 | 5% |
New treatment approaches | 6 | 4% |
Other research | 3 | 2% |
Du Y (2026). [PMID: 41540036](https://pubmed.ncbi.nlm.nih.gov/41540036/). *Cell Death Dis*. [Basic Science / Preclinical]
Yuan Y (2026). [PMID: 41203184](https://pubmed.ncbi.nlm.nih.gov/41203184/). *Cell Signal*. [Basic Science / Preclinical]
Yi X (2026). [PMID: 41580160](https://pubmed.ncbi.nlm.nih.gov/41580160/). *Toxicol Appl Pharmacol*. [Diagnostic / Biomarker]
Liu Z (2026). [PMID: 41312723](https://pubmed.ncbi.nlm.nih.gov/41312723/). *Mol Med Rep*. [Review / Meta-Analysis]
Li J (2026). [PMID: 41568676](https://pubmed.ncbi.nlm.nih.gov/41568676/). *Artif Cells Nanomed Biotechnol*. [Diagnostic / Biomarker]
Lobo A (2026). [PMID: 41790060](https://pubmed.ncbi.nlm.nih.gov/41790060/). *Am J Surg Pathol*. [Epidemiology / Natural History]
Rodriguez M (2026). [PMID: 41632099](https://pubmed.ncbi.nlm.nih.gov/41632099/). *Cancer*. [Review / Meta-Analysis]
Zhang M (2026). [PMID: 40704447](https://pubmed.ncbi.nlm.nih.gov/40704447/). *Am J Surg Pathol*. [Basic Science / Preclinical]
Wu J (2026). [PMID: 41578672](https://pubmed.ncbi.nlm.nih.gov/41578672/). *Ann Med*. [Epidemiology / Natural History]
Trpkov K (2026). [PMID: 41384711](https://pubmed.ncbi.nlm.nih.gov/41384711/). *Histopathology*. [Review / Meta-Analysis]
AI-curated news mentioning renal cell carcinoma, Xp11-associated
Updated Sep 3, 2026
Recent research expands the understanding of aggressive high-grade papillary-patterned renal cell carcinomas associated with FLCN mutations, highlighting their relevance in Birt-Hogg-Dubé syndrome and sporadic cases. This study provides new insights into the clinicopathological spectrum of these tumors.
A case study highlights metastatic renal cell carcinoma presenting as plantar fasciitis, emphasizing the need for awareness of atypical presentations of cancer. This review contributes to the understanding of renal cell carcinoma's diverse manifestations.
A recent study published in PubMed compares survival outcomes between clear cell and non-clear cell renal cell carcinoma in patients with cT1N0M0 disease. The findings contribute to understanding the prognosis of different renal cell carcinoma subtypes.